LabCAST

When the high dose (HD) group was divided into HD+ (NAb positive) and HD- (NAb negative) subgroups, they found:9

  • The HD- group had an inverse relationship between the total number of active lesions and mean NK cell FA
  • The HD+ group had a positive relationship between the total number of active lesions and mean NK cell FA

The authors suggested that the HD+ subgroup's exhibition of a positive relationship between NK cell FA and number of active lesions (similar to the relationship exhibited bythe placebo group) and the HD- subgroup's negative relationship "could suggest that neutralizing antibodies to IFN-b might interfere with the benefits of this cytokine."9 This observation is another interesting example of neutralizing antibodies modifying the action of IFN-b.

This article emphasizes that more research into the role of NK cells in multiple sclerosis is required, explaining "[a]lthough the results are consistentwiththe hypothesis that NK cells play a role in the immunopathogenesis of MS, they do not prove a causal relationship. ... If a causal relationship between NK cell FA and disease activity in MS does exist, it would be important to define the mechanisms mediating the effect."9

Studying the effects of various treatments, such as IFN-b, could help researchers understand immune mechanisms that may be relevant in multiple sclerosis. The authors concluded: "Although the role of T cells in MS continues to be a major focus, our studies suggest that NK cells and, in particular, NK cell subsets might also merit additional investigation."9

 

  
1 2 3 4 5
Your understanding of the disease or condition
How you will diagnose patients with this disorder
How you will explain the disease or condition to patients and their families
None of the above

Breaking news in genetics
Dementias
Epilepsy
Mitochondrial disorders
Movement disorders
Multiple sclerosis
Neuromuscular disorders
Pediatric disorders
More information on Athena's MS & NAbs testing services
 
Please have a local sales rep contact me
 
 
 
 
 
NAbs and Natural Killer Cells
Back
Conclusion
Next